Delivery of endostatin in experimental cancer therapy

International Journal of Experimental Pathology

Volumn 83, Issue 6, 2002, Pages 265-274

  Sorensen, Dag R ^a   Read, Tracy Ann ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Cancer; Delivery; Endostatin

Indexed keywords

ENDOSTATIN; LIPOSOME; POVIDONE; RECOMBINANT PROTEIN;

ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COLON CARCINOMA; CRYSTAL STRUCTURE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; GENE TRANSFER; HEAD AND NECK CARCINOMA; HUMAN; IN VITRO STUDY; KIDNEY CARCINOMA; MELANOMA; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SARCOMA; TOXICITY TESTING;

ANGIOGENESIS INHIBITORS; ANIMALS; BIOREACTORS; CLINICAL TRIALS, PHASE I; COLLAGEN; COLLAGEN TYPE XVIII; ENDOSTATINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NEOPLASMS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

EID: 0036969956     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2002.00240.x     Document Type: Review

References (67)

1. BERGER A.C., FELDMAN A.L., GNANT M.F. ET AL. (2000) The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J. Surg. Res. 91, 26-31.
2. BLEZINGER P., WANG J., GONDO M. ET AL. (1999) Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat. Biotechnol. 17, 343-348.
3. BLOCH W., HUGGEL K., SASAKI T. ET AL. (2000) The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. Faseb J. 14, 2373-2376.
4. BOEHLE A.S., KURDOW R., SCHULZE M. ET AL. (2001) Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model. Int. J. Cancer. 94, 420-428.
5. BOEHM T., FOLKMAN J., BROWDER T. & O'REILLY M.S. (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404-407.
6. CARMELIET P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.
7. CHEN Q.R., KUMAR D., STASS S.A. & MIXON A.J. (1999) Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res. 59, 3308-3312.
8. DHANABAL M., RAMCHANDRAN R., VOLK R. ET AL. (1999a) Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res. 59, 189-197.
9. DHANABAL M., VOLK R., RAMCHANDRAN R., SIMONS M. & SUKHATME V.P. (1999b) Cloning, expression, and in vitro activity of human endostatin. Biochem. Biophys. Res. Commun. 258, 345-352.
10. DHANABAL M., RAMCHANDRAN R., WATERMAN M.J. ET AL. (1999c) Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726.
11. DING I., SUN J.Z., FENTON B. ET AL. (2001) Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. Cancer Res. 61, 526-531.
12. DING Y.H., JAVAHERIAN K., LO K.M. ET AL. (1998) Zinc-dependent dimers observed in crystals of human endostatin. Proc. Natl. Acad. Sci. USA 95, 10443-10448.
13. DIXELIUS J., CROSS M., MATSUMOTO T., SASAKI T., TIMPL R. & CLAESSON-WELSH L. (2002) Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res. 62, 1944-1947.
14. FELDMAN A.L., ALEXANDER H.R., HEWITT S.M., LORANG D., THIRUVATHUKAL C.E., TURNER E.M. & LIBUTTI S.K. (2001) Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors.
15. FELBOR U., DREIER L., BRYANT R.A., PLOEGH H.L., OLSEN B.R. & MOTHES W. (2000) Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19, 1187-1194.
16. FOLKMAN J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186.
17. FUKAI N., EKLUND L., MARNEROS A.G. ET AL. (2002) Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21, 1535-1544.
18. GALE N.W. & YANCOPOULOS G.D. (1999) Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055-1066.
19. GOLDMAN E. (1907) The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 2, 1236-1240.
20. GREENBERGER J.S. (2000) Antitumor interaction of short course endostatin and ionizing radiation. Cancer J. 6, 279-281.
21. HANAI J.I., DHANABAL M., KARUMANCHI S.A. ET AL. (2002) Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J. Biol. Chem. 19, 1644-1649.
22. HANNA N.N., SEETHARAM S., MAUCERI H.J. ET AL. (2000) Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J. 6, 287-293.
23. HARTFORD A.C., GOHONGI T., FUKUMURA D. & JAIN R.K. (2000) Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential rote of host-tumor interaction. Cancer Res. 60, 2128-2131.
24. HOHENESTER E., SASAKI T., OLSEN B.R. & TIMPL R. (1998) Crystal structure of the angiogenesis inhibitor endostatin at 1. 5 a Resolution. EMBO J. 17, 1656-1664.
25. HUANO X., WONG M.K., ZHAO Q. ET AL. (2001) Soluble recombinant endostatin purified from Escherichia Coli. antiangiogenic activity and antitumour effect. Cancer Res. 61, 478-481.
26. JOKI T., MACHLUFT M., ATALA A. ET AL. (2001) Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19, 35-39.
27. KARUMANCHI S.A., JHA V., RAMCHANDRAN R. ET AL. (2001) Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell. 7, 811-822.
28. KIM Y.M., JANG J.W., LEE O.H. ET AL. (2000) Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res. 60, 5410-5413.
29. KISKER O., BECKER C.M., PROX D. ET AL. (2001) Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res. 61, 7669-7674.
30. KRUGER E.A., DURAY P.H., TSOKOS M.G. ET AL. (2000) Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. Biochem. Biophys. Res. Commun. 268, 183-191.
31. Kuo C.J., FARNEBO F., YU E.Y. ET AL. (2001) Comparative evaluation of the antitumor activity of anti-angiogenic proteins delivered by gene transfer. Proc. Natl. Acad. Sci. USA 98, 4605-4610.
32. LAWLER J. (2000) The functions of thrombospondin-1 and -2. Curr. Opin. Cell Biol. 12, 634-640.
33. MACDONALD N.J., SHIVERS W.Y., NARUM D.L. ET AL. (2001) Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin. J. Biol. Chem. 276, 25190-25196.
34. MARNEROS A.G. & OLSEN B.R. (2001) The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 20, 337-345.
35. MAYSINGER D., BEREZOVSKAYA O. & FEDOROFF S. (1996) The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS: (II). Microencapsulated CSF-1 and LM-10 cells as delivery systems. Exp. Neurol. 141, 47-56.
36. MURAGAKI Y., TIMMONS S., GRIFFITH C.M. ET AL. (1995) Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl. Acad. Sci. USA 92, 8763-8767.
37. NGUYEN J.T., WU P., CLOUSE M.E., HLATKY L. & TERWILLIGER E.F. (1998) Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. Cancer Res. 58, 5673-5677.
38. O'REILLY M.S., BOEHM T., SHING Y. ET AL. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88, 277-285.
39. O'REILLY M.S., HOLMGREN L. ET AL. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
40. OH S.P., KAMAGATA Y., MURAGAKI Y., TIMMONS S., OOSHIMA A. & OLSEN B.R. (1994) Isolation and sequencing of CDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Nat. Acad. Sci. USA 91, 4229-4233.
41. PERLETTI G., CONCARI P., GIARDINI R. ET AL. (2000) Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer Res. 7, 1793-1796.
42. RATEL D., NASSER V., DUPRE I., BENABID A.L. & BERGER F. (2000) Antibodies to endostatin in a multifocal glioblastoma patient. Lancet 356, 1656-1657.
43. READ T.A., FARHADI M., BJERKVIG R. ET AL. (2001a) Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells. Cancer Res. 61, 6830-6837.
44. READ T.A., SORENSEN D.R., MAHESPARAN R. ET AL. (2001b) Local endostatin treatment of gliomas administered by micro-encapsulated producer cells. Nat. Biotechnol. 19, 29-34.
45. REGULIER E., PAUL S., MARIGLIANO M. ET AL. (2001) Adenovirus-mediated delivery of anti-angiogenic genes as an antitumor approach. Cancer Gene Ther. 1, 45-54.
46. REHN M., VEIKKOLA T., KUKK-VALDRE E. ET AL. (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98, 1024-1029.
47. SAARELA J., REHN M., OIKARINEN A., AUTIO-HARMAINEN H. & PIHLAJANIEMI T. (1998) The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am. J. Pathol. 153, 611-626.
48. SACCO M.G., CATO E.M., CERUTI R. ET AL. (2001) Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice. Gene Ther. 8, 67-70.
49. SASAKI T., FUKAI N., MANN K., GOHRING W., OLSEN B.R. & TIMPL R. (1998) Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17, 4249-4256.
50. SASAKI T., LARSSON H., KREUGER J. ET AL. (1999) Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18, 6240-6248.
51. SCAPPATICCI F.A., SMITH R., PATHAK A. ET AL. (2001) Combination angiostatin and endostatin gene transfer induces synergistic anti-angiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. Mol. Ther. 3, 186-196.
52. 2 homoestasis. Curr. Opin. Genetics Dev. 8, 588-594.
53. SHICHINOHE T., BOCHNER B.H., MIZUTANI K. ET AL. (2001) Development of lentiviral vectors for anti-angiogenic gene delivery. Cancer Gene Ther. 8, 879-889.
54. SIM B.K., MACDONALD N.J. & GUBISH E.R. (2000) Angiostatin and endostatin: endogenous inhibitors of tumor growth. Cancer Metastasis Rev. 19, 181-190.
55. SORENSEN D.R., READ T.-A., PORWOL T. ET AL. (2002) Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma. Neuro-Oncology. 4, 1-8.
56. ST CROIX B., RAGO C., VELCULESCU V. ET AL. (2000) Genes expressed in human tumor endothelium. Science. 289, 1197-1202.
57. STANDKER L., SCHRADER M., KANSE S.M., JURGENS M., FORSSMANN W.G. & PREISSNER K.T. (1997) Isolation and characterization of the circulating form of human endostatin. FEBS Lett. 420, 129-133.
58. SAUTER B.U., MARTINET O., ZHANG W.J., MANDELI J. & WOO S.L. Adenovirus-mediated genetransfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases (2000) Proc. Natl. Acad. Sci. USA 97, 4802-4807.
59. SZARY J. & SZALA S. (2001) Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth. Int. J. Cancer 91, 835-839.
60. THORSEN F., READ T.A., LUND-JOHANSEN M., TYSNES B.B. & BJERKVIG R. (2000) Alginate-encapsulated producer cells: a potential new approach for the treatment of malignant brain tumors. Cell Transplant. 6, 773-783.
61. TREPEL M., GRIFMAN M., WEITZMAN M.D. & PASQUALINI R. (2000) Molecular adaptors for vascular-targeted adenoviral gene delivery. Hum. Gene Ther. 11, 1971-1981.
62. WEN W., MOSES M., WIEDERSCHAIN D., ARBISER J.L. & FAKMAN J. (1999) The generation of endostatin is mediated by elastase. Cancer Res. 59, 6052-6056.
63. WEN X.Y., BAI Y. & STEWART A.K. (2001) Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice. Hum. Gene Ther. 12, 347-358.
64. WINN S.R., TRESCO P.A., ZIELINSKI B., GREENE L.A., JAEGER C.B. & AEBISCHER P. (1991) Behavioural recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113, 322-329.
65. YAMAGUCHI N., ANAND-APTE B., LEE M. ET AL. (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18, 4414-4423.
66. YAMANAKA R., ZULLO S.A., RAMSEY J. ET AL. (2001) Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus. Cancer Gene Ther. 8, 796-802.
67. YOU W.K., SO S.H., LEE H., PARK S.Y. ET AL. (1999) Purification and characterization of recombinant murine endostatin in E. coli. Exp. Mol. Med. 4, 197-202.